UNSPSC 85523606: Restriction of right cephalic vein with extraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of right cephalic vein with extraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05VD3CZ

UNSPSC 85523606 Restriction of right cephalic vein with extraluminal device, percutaneous approach is a Commodity code tagged to state and local solicitations that show minimal alignment with its nominal medical-device scope. Recent opportunities posted under this code do not reflect procurement of vascular restriction devices or related medical equipment. Instead, issuing bodies have tagged disability medical evaluation services, pharmacy benefit management, occupational medical surveillance, specialty surgical networks, and temporary health professional staffing—none of which involve vascular intervention devices or percutaneous procedures. The code appears to function as a catch-all category for health-services-adjacent procurements rather than a targeted marker for the specific clinical procedure and device the code name describes.

The geographic and issuing-body spread reflects diversified state and local health procurement activity: Phoenix's retirement office (medical evaluations for pension disability determinations), Long Beach (surgical carve-out networks), Washington State Department of Transportation (occupational health surveillance), Harris County Juvenile Probation, Collier County (pharmacy benefit management), and Santa Clara County Health System (temporary health professional staffing). Recent opportunities span Arizona, California, Florida, and Washington with response windows from September through October 2026. Given the mismatch between the code's device-specific name and the actual work being solicited—none of which involves vascular devices—vendors pursuing this code should treat recent activity as a misfiled portfolio rather than a reliable signal of demand for restriction-device procurement or related interventional services.